The retatrutide CAS number is 2381089-83-2. For research teams, that number is a practical starting point for distinguishing retatrutide from similarly named peptides, related development compounds, and incomplete catalog entries. It is not, however, a substitute for analytical documentation, sequence confirmation, or lot-specific quality review.

Retatrutide is commonly identified in scientific and commercial research records by the development code LY3437943. Because peptide naming can vary between publications, supplier catalogs, databases, and internal inventory systems, a disciplined identity check should use more than one reference point. The CAS number helps establish a shared record, while the compound name, development code, molecular information, and analytical data provide the context needed to evaluate the material itself.

Retatrutide CAS Number: What It Identifies

A Chemical Abstracts Service Registry Number, commonly called a CAS number, is a unique numerical identifier assigned to a chemical substance in the CAS Registry. The retatrutide CAS number, 2381089-83-2, is formatted as three groups of digits separated by hyphens. The final digit is a check digit used to help detect transcription errors.

Unlike a product name, a CAS number is designed to remain specific even when naming conventions differ. This matters with peptide research materials, where a compound may appear under a nonproprietary name, a development code, a sequence-based description, or an abbreviated catalog designation. A CAS number can reduce ambiguity during procurement, document review, inventory reconciliation, and literature searching.

Still, the identifier answers a narrow question: which registered substance is being referenced? It does not establish whether a particular vial, lot, or listing is authentic, correctly labeled, intact, or suitable for a defined research workflow. Those questions require documentation and analytical evidence tied to the actual lot.

Why a CAS Number Alone Is Not Enough

Research purchasers sometimes treat a matching CAS number as an identity guarantee. That is understandable, but it is not a sufficient quality-control practice. A CAS number is an indexing tool, not a certificate of analysis and not a measurement of purity.

For a complex synthetic peptide such as retatrutide, the most useful identity assessment brings together several records. The supplier’s stated compound name and CAS number should align with the development code where applicable. The reported molecular mass should be plausible for the stated peptide construct. A lot-specific certificate of analysis should identify the lot and describe the test methods used. Chromatographic and mass-spectrometric records should be interpreted as supporting evidence rather than as generic marketing claims.

This distinction is especially relevant when reviewing research catalogs. Two listings can display the same retatrutide CAS number while providing very different levels of traceability. One may provide a lot number, method details, chromatographic purity result, and mass confirmation. Another may supply only a CAS number and a broad purity statement with no underlying documentation. The identifier may match in both cases, but the quality of the purchasing record does not.

Core Identifiers for Retatrutide Research Records

A clean material record should connect the retatrutide CAS number with the other identifiers used by the laboratory. At minimum, researchers should record the name retatrutide, CAS number 2381089-83-2, relevant synonym or development code LY3437943, supplier, catalog number, lot number, receipt date, and storage conditions specified by the supplier.

The exact material description also matters. Peptide products can differ in salt form, counterion information, packaging, nominal mass, and stated purity basis. These attributes are not administrative details. They can affect how a material is compared against a method, reference record, or previously received lot.

For internal inventories, avoid shortening the record to a casual label such as “reta.” Abbreviations may be convenient at the bench, but they create avoidable uncertainty when data are transferred between team members or reviewed months later. A structured label that includes the full compound name and lot number is more reliable, with the CAS number retained in the electronic inventory record.

How to Verify a Retatrutide Listing Before Procurement

Verification should begin before an order is placed, not after materials arrive. Confirm that the product page, quotation, or technical document consistently identifies the compound as retatrutide and lists the CAS number as 2381089-83-2. If a development code is shown, it should correspond to LY3437943 rather than an unrelated investigational compound.

Next, request or review the analytical documentation available for the specific product line. For peptide research materials, reverse-phase HPLC is commonly used to characterize chromatographic purity, while LC-MS can support molecular identity confirmation. Neither technique should be viewed in isolation. HPLC may reveal major chromatographic components but does not independently establish sequence identity. Mass spectrometry can support expected mass confirmation but may not resolve all structurally similar impurities. Together, along with transparent method reporting, they provide a stronger basis for review.

Researchers should also distinguish between a general specification and a lot-specific result. A statement such as “purity greater than 99%” is a specification unless it is linked to a named lot, a test report, and an identified method. A certificate of analysis should make it possible to associate the reported result with the material being received.

At Biotech Labz Supply, qualified research purchasers should treat available lot documentation and analytical records as central procurement criteria, alongside the retatrutide CAS number. This approach supports traceable purchasing rather than reliance on labels alone.

Common Catalog and Documentation Errors

Most identifier problems are not dramatic fraud events. They are routine record-control failures: a copied CAS number, an outdated synonym, a document attached to the wrong product, or a lot number that does not match the package received.

One common issue is confusing a research compound’s development code with a final or alternate compound name. Another is relying on an aggregator database that reproduces information from multiple sources without showing the underlying analytical basis. Search results can be useful for discovery, but the supplier’s lot documentation and the laboratory’s own incoming-material controls should govern acceptance decisions.

A second issue is failing to account for peptide complexity. Retatrutide is a modified peptide, not a simple small molecule with a short formula and a single uncomplicated identity check. Its analytical review should reflect that complexity. Researchers evaluating a new source or lot may need to consider chromatographic profile, observed mass, documentation completeness, packaging integrity, and chain-of-custody requirements for their organization.

Retatrutide CAS Number FAQs

Is 2381089-83-2 the CAS number for retatrutide?

Yes. Retatrutide is associated with CAS number 2381089-83-2. It may also be encountered under the development designation LY3437943 in research documentation.

Does a matching CAS number prove a product is genuine?

No. A matching CAS number indicates that the listing is intended to refer to the same registered substance. It does not verify the identity, purity, composition, handling history, or analytical status of a specific lot. Review lot-specific records and supporting analytical data.

Should a CAS number appear on a certificate of analysis?

It is useful for the CAS number to appear on a certificate of analysis or accompanying product record, but it should be accompanied by the product name, lot number, test results, test methods, and documentation date. Those details connect the document to the material under review.

What is the best way to record retatrutide in a laboratory inventory?

Record the full name, retatrutide; CAS number 2381089-83-2; development code LY3437943 where relevant; supplier catalog number; lot number; received quantity; receipt date; and the supplier’s stated storage requirements. Retain the associated analytical documentation in the same controlled record.

The right CAS number helps researchers find the right record. The right documentation, analytical review, and lot control help researchers decide whether that record is fit for their laboratory’s research standards.

Verified by MonsterInsights